Countries China
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines ...
May 15, 2024 | News
Eisai Co., Ltd. announced that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) Fycompa&...
May 14, 2024 | News
Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targ...
May 14, 2024 | News
Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need,...
May 14, 2024 | News
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...
May 13, 2024 | News
NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...
May 10, 2024 | News
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of Genera...
May 09, 2024 | News
Biocytogen Pharmaceuticals, a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antib...
May 07, 2024 | News
Shineco, a provider of technologically advanced healthcare products and services, announced that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. a...
May 02, 2024 | News
Shenzhen Chipscreen Biosciences announced that the company's lead innovative product Chidamide (Epidaza®) , an oral subtype-selective histone deacetyla...
May 01, 2024 | News
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at th...
May 01, 2024 | News
First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...
April 30, 2024 | Company results
Sino Biological, Inc. , a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, specializing in biological research reagents...
April 29, 2024 | News
Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases...
April 25, 2024 | News
Most Read
Bio Jobs
News
Editor Picks